Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Nonprotective Role of Losartan in Cisplatin-Induced Nephrotoxicity in Ovariectomized Rat Model Treated With Estradiol Publisher



Ghadirian F1, 2 ; Nematbakhsh M1, 3, 4 ; Roozbehani S2 ; Mazaheri S1 ; Talebi A5 ; Pezeshki Z1 ; Ashrafi F6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Water and Electrolytes Research Center, Islamic Azad University, Isfahan, Iran
  2. 2. Department of Biology, Falavarjan Branch, Islamic Azad University, Isfahan, Iran
  3. 3. Departments of Physiology, Islamic Azad University, Water and Electrolytes Research Center, Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Isfahan MN Institute of Basic and Applied Sciences Research, Isfahan, Iran
  5. 5. Departments of Clinical Pathology, Islamic Azad University, Isfahan, Iran
  6. 6. Departments of Internal Medicine, University of Medical Sciences, Islamic Azad University, Isfahan, Iran

Source: Journal of Pharmaceutical Negative Results Published:2015


Abstract

Objective: The aim was to study the role of losartan on cisplatin (CP).induced nephrotoxicity in an estradiol replacement rat model. Materials and Methods: Forty.seven female Wistar rats were ovariectomized and divided into seven groups. Groups 1 and 2 were treated with placebo (sesame oil) on a weekly basis for 4 weeks, and then they received saline or CP (2.5 mg/kg/day) for the next 7 days, respectively. Group 3 received estradiol (250 μg/kg/week) for 4 weeks, and then treated with losartan (10 mg/kg/day) for the next 10 days while from day 3; they also received CP for 7 days. Group 4 had treatment regimen the same as Group 3, except saline instead of losartan. Groups 5 and 6 were treated similar to Groups 3 and 4, respectively, but the dose of estradiol was doubled. Finally, Group 7 was treated as Group 3 except vehicle instead of estradiol. At the end of the experiment, blood samples were obtained to measure blood urea nitrogen (BUN), creatinine (Cr), nitric oxide metabolite (nitrite) and malondialdehyde (MDA). The kidney tissues were also subjected to pathology investigations. Results: Cisplatin significantly increased the serum level of BUN, Cr, and MDA (P < 0.05). CP also increased kidney weight (KW) and kidney tissue damage score (KTDS), and decreased bodyweight significantly (P < 0.05). There is a significant difference in KTDS, weight changes and serum level of MDA between positive control groups compared with the groups received combination of losartan and CP (P < 0.05). Conclusions: It seems that the estrogen could promote CP.induced nephrotoxicity. Losartan also did not intensify CP.induced nephrotoxicity. Accordingly, supplementation of losartan to attenuate CP.induced nephrotoxicity in ovariectomized model treated with estradiol is not suggested.
Other Related Docs
9. Cisplatin-Induced Nephrotoxicity; Protective Supplements and Gender Differences, Asian Pacific Journal of Cancer Prevention (2017)
23. Effect of Short Hydration on Cisplatin-Induced Nephrotoxicity in Cancer Patients: A Retrospective Study, International Journal of Hematology-Oncology and Stem Cell Research (2017)
30. Cisplatin-Induced Renal Toxicity: A Short Review, Life Science Journal (2014)
35. Age and Gender Related Renal Side Effects of Cisplatin in Animal Model, Asian Pacific Journal of Cancer Prevention (2017)
42. Cisplatin Nephrotoxicity May Be Sex Related, Kidney International (2013)